Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal
This study has been terminated.
Study NCT00333060   Information provided by Othera Pharmaceuticals

First Received on May 31, 2006.   Last Updated on March 31, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epiretinal Membrane
Macular Hole
Additional conditions recognized in this trial
Cataract
Retinal Perforations
More general conditions related to this trial
Eye Diseases
Lens Diseases
Retinal Diseases
Interventions listed in this trial
OT-551 ophthalmic solution
Sponsors listed in this trial
Othera Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services